Rebecca Byam insider trades
Open-market stock purchases and sales by Rebecca Byam, Chief Financial Officer at HCW Biologics Inc, from SEC Form 4 filings since Jul 22, 2021.
Track record: 0% of 31 scored buys are up 5% or more since purchase, averaging -51%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 22, 2026 | HCWB HCW Biologics Inc | Bought | — |
Companies traded
- HCWB HCW Biologics Inc: 33 buys, last May 22, 2026